Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.
-
Cai CX, Hribar M, Baxter S, Goetz K, Swaminathan SS, Flowers A, Brown EN, Toy B, Xu B, Chen J, Chen A, Wang S, Lee C, Leng T, Ehrlich JR, Barkmeier A, Armbrust KR, Boland MV, Dorr D, Boyce D, Alshammari T, Swerdel J, Suchard MA, Schuemie M, Bu F, Sena AG, Hripcsak G, Nishimura A, Nagy P, Falconer T, DuVall SL, Matheny M, Viernes B, O'Brien W, Zhang L, Martin B, Westlund E, Mathioudakis N, Fan R, Wilcox A, Lai A, Stocking JC, Takkouche S, Lee LH, Xie Y, Humes I, McCoy DB, Adibuzzaman M, Areaux RG, Rojas-Carabali W, Brash J, Lee DA, Weiskopf NG, Mawn L, Agrawal R, Morgan-Cooper H, Desai P, Ryan PB. Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy. JAMA Ophthalmol. 2025 Apr 01; 143(4):304-314.
-
LaRovere KL, Asaro LA, Coughlin-Wells K, Nadkarni VM, Agus MSD. Blood Glucose Range for Hyperglycemic PICU Children With Primary Neurologic Diagnoses: Analysis of the Heart and Lung Failure-Pediatric Insulin Titration (HALF-PINT) Trial. Pediatr Crit Care Med. 2025 Apr 01; 26(4):e432-e446.
-
Pallauf M, Br?nimann S, Rezaee ME, Kohn TP, Fletcher SA, McNamara M, Enikeev D, Shariat SF, Hoffman-Censits J, Smith AK, Singla N. Metformin intake and risk of metabolic acidosis after radical cystectomy with urinary diversion: A comparative study using data from the TriNetX research network. Urol Oncol. 2025 07; 43(7):441.e11-441.e18.
-
Amaral DC, Guedes J, Cruz MRB, Cheidde L, Nepomuceno M, Magalh?es PLM, Brazuna R, Mora-Paez DJ, Huang P, Razeghinejad R, Schuman JS, Myers JS. GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2025 Mar; 271:488-497.
-
Simonson DC, Testa MA, Ekholm E, Su M, Vilsb?ll T, Jabbour SA, Lind M. Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine. J Clin Endocrinol Metab. 2024 Nov 18; 109(12):e2261-e2272.
-
Dasgupta I, Zac-Varghese S, Chaudhry K, McCafferty K, Winocour P, Chowdhury TA, Bellary S, Goldet G, Wahba M, De P, Frankel AH, Montero RM, Lioudaki E, Banerjee D, Mallik R, Sharif A, Kanumilli N, Milne N, Patel DC, Dhatariya K, Bain SC, Karalliedde J. Current management of chronic kidney disease in type-2 diabetes-A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) guidelines. Diabet Med. 2025 Feb; 42(2):e15450.
-
Venkatesh KK, MacPherson C, Clifton RG, Powe CE, Bartholomew A, Gregory D, Trinh A, McAlearney AS, Fiechtner LG, Catalano P, Rice D, Cross S, Kutay H, Gabbe S, Grobman WA, Costantine MM, Battarbee AN, Boggess K, Katukuri V, Eichelberger K, Esakoff T, Feghali MN, Harper L, Kaimal A, Kole-White M, Mendez-Figueroa H, Mlynarczyk M, Sciscione A, Shook L, Sobhani NC, Stamilio DM, Werner E, Wiegand S, Zera CA, Zork NM, Saade G, Landon MB. Comparative effectiveness trial of metformin versus insulin for the treatment of gestational diabetes in the USA: clinical trial protocol for the multicentre DECIDE study. BMJ Open. 2024 09 24; 14(9):e091176.
-
Kelly MS, Scopelliti EM, Goodson KE, Lo CMA, Nguyen HX, Simon B. Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2024 12; 26(12):5661-5668.
-
Mohr A, de Souza Barbosa F, Wingert NR, Takeuchi CK, Garcia L, Ribeiro MFN, Arbo MD, de Oliveira TF, Steppe M. Analysis of omarigliptin forced degradation products by ultra-fast liquid chromatography, mass spectrometry, and in vitro toxicity assay. Biomed Chromatogr. 2024 Aug; 38(8):e5904.
-
Laine C, Moyer DV, Qaseem A. Newer Pharmacologic Treatments for Type 2 Diabetes. Ann Intern Med. 2024 Jul; 177(7):968-969.